AMGN News

Amgen Whale Trades Spotted

AMGN

A whale with a lot of money to spend has taken a noticeably bearish stance on Amgen. Looking at options history for Amgen (NASDAQ:AMGN) we detected 22 strange trades.

September 13, 2022
Read more →

Livent, Amgen And Some Other Big Stocks Moving Lower On Monday

AMGN

U.S. stocks traded higher, with the Dow Jones gaining more than 250 points on Monday. Here are some big stocks recording gains in today’s session.

September 12, 2022
Read more →

'Data Likely Support Approval Of Amgen's KRAS-targeted Drug, But Still Come With Disappointments' -Stat News

AMGN

September 12, 2022
Read more →

Here's Why Amgen Shares Are Diving

AMGN

Amgen, Inc. (NASDAQ: AMGN) shares are trading lower by 4.11% to $237.51 during Monday's pre-market session following FDA approval of Bristol Myers Squibb Co's (NYSE: BMY) plaque psoriasis drug Sotyktu, which s

September 12, 2022
Read more →

Amgen's Lumakras Cuts Risk Of Progression By 34% In KRAS-Mutated Lung Cancer Patients

AMGN

September 12, 2022
Read more →

Bristol Myers' Deucravacitinib Scores FDA Approval For Plaque Psoriasis

AMGN

September 12, 2022
Read more →

Amgen Says SPROUT Data Show Otezla Resulted In 'Significant Improvements' In Measures Of Moderate To Severe Plaque Psoriasis At Week 16 Compared With Placebo In Children Ages 6-17

AMGN

September 8, 2022
Read more →

Analyzing Amgen's Short Interest

AMGN

Amgen's (NASDAQ:AMGN) short percent of float has fallen 7.95% since its last report. The company recently reported that it has 22.52 million shares sold short, which is 4.05% of all regular shares that are available for trading.

May 2, 2022
Read more →

Here's How Much $100 Invested In Amgen 10 Years Ago Would Be Worth Today

AMGN

Amgen (NASDAQ:AMGN) has outperformed the market over the past 10 years by 1.04% on an annualized basis producing an average annual return of 12.67%. Currently, Amgen has a market capitalization of $124.75 billion.

April 29, 2022
Read more →

Markets Surge Despite Drop In US GDP

AMGN

U.S. indices traded higher Thursday despite a drop in U.S. GDP. Strength in stocks is possibly due to better-than-expected quarterly earnings from multiple companies as well as a rebound following a selloff earlier in the week.

April 28, 2022
Read more →

Check Out What Whales Are Doing With AMGN

AMGN

A whale with a lot of money to spend has taken a noticeably bearish stance on Amgen. Looking at options history for Amgen (NASDAQ:AMGN) we detected 18 strange trades.

April 28, 2022
Read more →

Piper Sandler Maintains Overweight Rating for Amgen: Here's What You Need To Know

AMGN

Piper Sandler has decided to maintain its Overweight rating of Amgen (NASDAQ:AMGN) and raise its price target from $255.00 to $260.00. Shares of Amgen are trading down 5.5% over the last 24 hours, at $235.12 per share. A move to $260.00 would account for a 10.58% increase from the current share price.

April 28, 2022
Read more →

BioMarin Achieves Record Q1 Sales Driven By Recently Approved Achondroplasia Therapy

AMGN

April 28, 2022
Read more →

Why Amgen Shares Are Trading Lower

AMGN

Amgen, Inc. (NASDAQ: AMGN) shares are trading lower by 6.21% at $233.33 after the company reported first-quarter earnings results.

April 28, 2022
Read more →

Amgen's Return On Capital Employed Insights

AMGN

Pulled from Benzinga Pro data, Amgen (NASDAQ:AMGN) posted Q1 earnings of $1.48 billion, an increase from Q4 of 22.27%. Sales dropped to $6.24 billion, a 8.88% decrease between quarters.

April 28, 2022
Read more →

Where Amgen Stands With Analysts

AMGN

Within the last quarter, Amgen (NASDAQ:AMGN) has observed the following analyst ratings:

April 28, 2022
Read more →

RBC Capital Maintains Sector Perform on Amgen, Raises Price Target to $223

AMGN

April 28, 2022
Read more →

BMO Capital Maintains Market Perform on Amgen, Lowers Price Target to $243

AMGN

April 28, 2022
Read more →

Piper Sandler Maintains Overweight on Amgen, Raises Price Target to $260

AMGN

April 28, 2022
Read more →

Amgen's Q1 Better Than Expected Sales, Profit Overshadowed By Tax Disclosure

AMGN

Amgen Inc (NASDAQ: AMGN) has recently received a notice of deficiency from the Internal Revenue Service centered on 2013 to 2015.

April 28, 2022
Read more →